You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

oxaliplatin

Pronunciation: ox-AL-ih-plah-tin
Appearance: clear, colourless solution mixed into larger bags of fluids

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Drug Monograph

Oct 2023
Table of Contents
Eligibility Forms
pdf download Oxaliplatin (EBP) - Colorectal Cancer Patients with Resectable or Potentially Resectable Extrahepatic Metastases pdf download Oxaliplatin (EBP) - Supplemental 1 pdf download Oxaliplatin (EBP) - Supplemental 2

Patient Info Sheet

Oct 2023

What it is used for

  • For treating certain types of cancers such as colorectal, pancreatic and stomach cancer, usually in combination with other drugs (such as 5-fluorouracil). It may also be used to treat other types of cancers.


You might also be interested in

Funding & Reimbursement

Several payment sources exist for cancer drugs in Ontario, depending on the drug, disease indication, and how and where it is delivered.

View Funding & Reimbursement

Symptom Management

Many people living with cancer experience nausea, diarrhea and other symptoms from their treatment or disease.

View Symptom Management

Drug Safety and Administration

Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.

View Drug Safety and Administration